Cartherics Pty Ltd

Cartherics Pty Ltd is a pioneering biotechnology company dedicated to developing innovative cancer therapies, particularly in the realm of cellular medicines for women’s health. Cartherics Pty Ltd strives to create precisely-defined immunotherapy treatments designed to combat a variety of cancers, leveraging a multi-platform approach that combines the best components of immune defenses, utilizing gene editing and CAR technology. This approach enables the development of more precise and accessible treatment options for patients. Located in Notting Hill, Victoria at 12 Ferntree Place, Cartherics Pty Ltd is focused on disrupting the tumor microenvironment (TME) to make tumors accessible to immune destruction.

The company's team boasts strong backgrounds in research, development, and product commercialization, allowing Cartherics Pty Ltd to push the boundaries of cell therapy for cancer. Through strategic partnerships with leading commercial and academic groups possessing complementary technology, Cartherics Pty Ltd is committed to developing new forms of solid cancer care treatment, ultimately helping patients fight cancer and regain control of their lives. Cartherics Pty Ltd is dedicated to improving patient outcomes and advancing the field of cancer treatment through its innovative and collaborative approach.

Cartherics Pty Ltd is continually expanding its efforts to address unmet needs in cancer therapy and remains committed to making a significant impact on patient care. We invite the manager of Cartherics Pty Ltd to create a customized and exclusive company showcase and product listing on our platform to further highlight your groundbreaking work. Information about Cartherics Pty Ltd will be completed soon with the support of the company’s management.